Thomas Fischer

5.5k total citations
110 papers, 3.1k citations indexed

About

Thomas Fischer is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Thomas Fischer has authored 110 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 40 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Thomas Fischer's work include Acute Myeloid Leukemia Research (41 papers), Chronic Myeloid Leukemia Treatments (37 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers). Thomas Fischer is often cited by papers focused on Acute Myeloid Leukemia Research (41 papers), Chronic Myeloid Leukemia Treatments (37 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers). Thomas Fischer collaborates with scholars based in Germany, United States and Australia. Thomas Fischer's co-authors include Thomas Kindler, Daniel B. Lipka, Florian H. Heidel, Frank Breitenbuecher, Simone M. Schoenwaelder, Magdalena Chrzanowska‐Wodnicka, Gilbert White, Susan S. Smyth, Stefan Kasper and Christopher M. Scull and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Thomas Fischer

96 papers receiving 3.0k citations

Peers

Countries citing papers authored by Thomas Fischer

Since Specialization

Citations

This map shows the geographic impact of Thomas Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fischer more than expected).

Fields of papers citing papers by Thomas Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fischer. The network helps show where Thomas Fischer may publish in the future.

Co-authorship network of co-authors of Thomas Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Fischer. A scholar is included among the top collaborators of Thomas Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Fischer. Thomas Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry 2024 ·Cell Communication and Signaling ·(unknown), Tobias Franz, (unknown), Martin Böttcher, Nicolas Chatain, Steffen Koschmieder, Tim H. Brümmendorf, (unknown), Burkhart Schraven, Sascha Kahlfuß, Thomas Fischer	4
2	Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction 2023 ·eLife ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marta Iannuccelli, (unknown), (unknown), (unknown), Patrizia Chiusolo, Gerardo Pepe, Manuela Helmer‐Citterich, (unknown), Martin Böttcher, Thomas Fischer, Livia Perfetto, Francesca Sacco	5
3	How ITD Insertion Sites Orchestrate the Biology and Disease of FLT3-ITD-Mutated Acute Myeloid Leukemia 2023 ·Cancers ·(unknown), Burkhart Schraven, Dimitrios Mougiakakos, Thomas Fischer	4
4	A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients 2022 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Natalie Krahmer, Thomas Fischer, Dimitrios Mougiakakos, Martin Boettcher, Livia Perfetto, Francesca Sacco	10
5	Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma 2021 ·European Journal Of Haematology ·Christian Straka, Hans Salwender, Stefan Knop, Martin Vogel, (unknown), Bernd Metzner, Christian Langer, Herbert G. Sayer, Wolfram Jung, Heinz Dürk, Florian Bassermann, Martin Gramatzki, Wolf Rösler, Hans‐Heinrich Wolf, Wolfram Brugger, Monika Engelhardt, Thomas Fischer, Peter Liebisch, Hermann Einsele	4
6	Optimized and Personalized Phlebotomy Schedules for Patients Suffering From Polycythemia Vera 2020 ·Frontiers in Physiology ·(unknown), (unknown), Enrico Schalk, Thomas Fischer, Sebastian Säger	3
7	Targeting RIPK1 in AML cells carrying FLT3‐ITD 2019 ·International Journal of Cancer ·(unknown), (unknown), Subbaiah Chary Nimmagadda, Thomas Fischer, Michael Naumann, Inna N. Lavrik	15
8	JAK2-V617F activates β1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1 2017 ·Leukemia ·(unknown), Bärbel Edelmann, (unknown), Felix Carl Saalfeld, Denise Wolleschak, Stefanie Kliche, Burkhart Schraven, Florian H. Heidel, Thomas Fischer	19
9	Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN 2017 ·Journal of Cancer Research and Clinical Oncology ·Tina M. Schnöder, Judith Eberhardt, Michael Koehler, Holger Bierhoff, Sönke Weinert, (unknown), Subbaiah Chary Nimmagadda, Denise Wolleschak, Korinna Jöhrens, Thomas Fischer, Florian H. Heidel	11
10	Kinomics Screening Identifies Aberrant Phosphorylation of CDC25C in FLT3-ITD-positive AML 2016 ·Anticancer Research ·Florian Perner, Tina M. Schnöder, Thomas Fischer, Florian H. Heidel	5
11	Strafgesetzbuch mit Nebengesetzen 2015 ·C.H.Beck eBooks ·Thomas Fischer, (unknown), Eduard Dreher, Herbert Tröndle	27
12	Quantitative tool to evaluate the somatic burden due to chemotherapy-induced adverse events: the somatic burden score 2014 ·Supportive Care in Cancer ·Michael Koehler, Thomas Fischer, Siegfried Kropf, Jörg Frommer	2
13	Der europäisch-US-amerikanische Koka(in)diskurs und seine Auswirkungen in den Anden,1870-1940 2014 ·Cases Journal ·Thomas Fischer	1
14	Epo-induced erythroid maturation is dependent on Plcγ1 signaling 2014 ·Cell Death and Differentiation ·Tina M. Schnöder, (unknown), (unknown), Lars Bullinger, Marcus Buschbeck, Steven Lane, Konstanze Döhner, Christoph Plass, Daniel B. Lipka, Florian H. Heidel, Thomas Fischer	22
15	Der Einfluss des Berichterstatters auf die Ergebnisse strafrechtlicher Revisionsverfahren 2013 ·Thomas Fischer	1
16	Molekularpathologie von Sarkomen 2010 ·Der Pathologe ·(unknown), Benedikt Brors, Thomas Fischer, (unknown), Wolfgang Hartmann, Peter Hohenberger, Peter Lichter, Alexander Marx, Gunhild Mechtersheimer, (unknown), Marcus Renner, Hans‐Ulrich Schildhaus, Peter Schirmacher, Elisabeth Sievers, Philipp Ströbel, Eva Wardelmann, (unknown), Reinhard Büttner	1
17	The Incidence of Myelofibrosis in Essential Thrombocythaemia, Polycythaemia vera and Chronic Idiopathic Myelofibrosis: A Retrospective Evaluation of Sequential Bone Marrow Biopsies 2005 ·Acta Haematologica ·Andreas Kreft, (unknown), (unknown), T. Buhr, Thomas Fischer, C. James Kirkpatrick	47
18	Rap1b is required for normal platelet function and hemostasis in mice 2005 ·Journal of Clinical Investigation ·Magdalena Chrzanowska‐Wodnicka, Susan S. Smyth, Simone M. Schoenwaelder, Thomas Fischer, Gilbert White	246
19	100 Deutsche Jahre 1998 ·Thomas Fischer, (unknown)	0
20	Grabungen in der spätkeltischen Siedlung im Sulztal bei Berching-Pollanten, Landkreis Neumarkt, Oberpfalz 1984 ·Germania: Anzeiger der Römisch-Germanischen Kommission des Deutschen Archäologischen Instituts ·Thomas Fischer, (unknown), Konrad Spindler, Angela von den Driesch	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact